UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000028332
Receipt No. R000032427
Scientific Title Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole
Date of disclosure of the study information 2017/07/24
Last modified on 2019/07/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole
Acronym Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole
Scientific Title Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole
Scientific Title:Acronym Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole
Region
Japan

Condition
Condition Lung cancer
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the change of tumor hypoxia in lung cancer using 18F-fluoromisonidazole after stereotactic radiotherapy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change of 18F-MISO uptake between before and after treatment
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 To perform F-MISO PET/CT before and 1 day after treatment
Interventions/Control_2 To perform F-MISO PET/CT before and 2 day after treatment
Interventions/Control_3 To perform F-MISO PET/CT before and 3 day after treatment
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >
Gender Male and Female
Key inclusion criteria 1)Adaptable of stereotactic radiotherapy for primary or metastatic lung malignant tumor less of equal 5cm. Fulfilling both of the following conditions and clinically diagnosed as NSCLC.
a) increase in tumor size of 1 mm or more, or consolidation/tumor ratio turning >50% from <=50% on CT scans performed 28 days or more apart.
b) positive accumulation on FDG-PET.
2)Performance status (ECOG): 0-2
3)Enable for performing PET/CT
4)Aged 20 to 84
5)signed informed consent
Key exclusion criteria 1)During the pregnancy or a pregnant female patient we are possible or are nursing.
2)The patient whom we merge psychosis or neurological manifestation, and it is judged to have difficulty with participation to an examination.
3)Severe complications whom enable to perform PET/CT
4)Other reasons with inadequate to enroll this trial
Target sample size 18

Research contact person
Name of lead principal investigator
1st name Yasumasa
Middle name
Last name Nishimura
Organization Kindai University
Division name Department of Radiation Oncology,
Zip code 5898511
Address 377-2,ohnohigashi,osakasayamashi,osaka
TEL 072-366-0221
Email im022012@med.kindai.ac.jp

Public contact
Name of contact person
1st name Masahiro
Middle name
Last name Inada
Organization Kindai University
Division name Department of Radiation Oncology,
Zip code 5898511
Address 377-2,ohnohigashi,osakasayamashi,osaka
TEL 072-366-0221
Homepage URL
Email im022012@med.kindai.ac.jp

Sponsor
Institute Kindai University
Institute
Department

Funding Source
Organization Kindai University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kindai Univarsity Faclty of medicine
Address Ohnohigashi 377-2, Osakasayama city, Osaka
Tel 0723880221
Email im022012@med.kindai.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 07 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2017 Year 03 Month 08 Day
Date of IRB
2016 Year 11 Month 08 Day
Anticipated trial start date
2017 Year 03 Month 08 Day
Last follow-up date
2023 Year 03 Month 08 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 07 Month 22 Day
Last modified on
2019 Year 07 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032427

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.